comparemela.com

A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say scientists at the University of Ca

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,British ,James Leiper ,Xuan Li ,Victor Phillip Dahdaleh ,British Heart Foundation ,Lung Research Institute At Cambridge ,Department Of Medicine ,University Of Cambridge ,Clinical Investigation ,Victor Phillip Dahdaleh Heart ,Lung Research Institute ,British Heart ,Professor James Leiper ,Associate Medical Director ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.